#NORML #News @WeedConnection

Share This

Survey: Super-Majority of Americans Oppose Federal Marijuana Prohibition

Washington, DC: Only two in ten Americans support the federal criminalization of marijuana, according to nationwide polling data compiled by YouGov.com.

Pollsters asked respondents whether cannabis use ought to be either "legalized nationally, left up to the states, or banned nationally."

Forty-five percent of those surveyed said that it should be legalized nationwide. Twenty-one percent of respondents said the decision to legalize cannabis should be left up to each individual state. Only 20 percent of those surveyed said they supported maintaining federal cannabis prohibition.

Democrats were far more likely than Republicans to support a policy of nationwide legalization.

Several pieces of legislation – including the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act and the States Reform Act – are pending in Congress to repeal federal marijuana prohibition, thereby permitting state governments to decide their own cannabis policies free from undue federal interference.

Study: Young Adults' Consumption of Alcohol, Cigarettes, Other Substances Fell Following Marijuana Legalization

Seattle, WA: Retail cannabis sales are associated with decreases in the use of alcohol, cigarettes, and pain medications by young adults, according to data published in the Journal of Adolescent Health.

Researchers with the University of Washington assessed trends in alcohol, nicotine, and non-prescribed pain reliever use among a cohort of over 12,500 young adults (ages 18 to 25) in Washington State following adult-use cannabis legalization.

They reported, "Contrary to concerns about spillover effects, implementation of legalized nonmedical cannabis coincided with decreases in alcohol and cigarette use and pain reliever misuse." Researchers did find that the prevalence of past-month e-cigarette use increased post-legalization.

Authors concluded, "Our findings add to evidence that the legalization of nonmedical cannabis has not led to dramatic increases in the use of alcohol, cigarettes, and nonprescribed opioids. … The findings indicate that the most critical public health concerns surrounding cannabis legalization and the evolution of legalized cannabis markets may be specific to cannabis use and related consequences."

Commenting on the study's findings, NORML's Deputy Director Paul Armentano said: "Real-world data from legalization states disputes longstanding claims that cannabis is some sort of 'gateway' substance. In fact, in many instances, cannabis regulation is associated with the decreased use of other substances, including many prescription medications."

Numerous prior studies, including those conducted by The RAND Corporation and the National Academy of Sciences, have disputed the so-called 'gateway theory' - concluding, "[M]arijuana has no causal influence over hard drug initiation."

According to nationwide polling compiled by YouGov.com, a majority of Americans no longer agree with the notion that "the use of marijuana leads to the use of hard drugs."

Full text of the study, "Trends in alcohol, cigarette, e-cigarette, and nonprescribed pain reliever use among young adults in Washington state after legalization of nonmedical cannabis," appears in the Journal of Adolescent Health.

Delaware: Lawmakers Advance Legislation Eliminating Marijuana Possession Penalties

Dover, DE: Majorities of lawmakers in the House and Senate have approved legislation, House Bill 371, eliminating penalties for the possession of up to one ounce of cannabis by adults.

House members voted 26 to 14 and Senate members voted 13 to 7 to advance the legislation. Virtually all Democrats voted for the measure while the majority of Republicans decided against it.

A spokesperson for Democratic Gov. John Carney said that he will review the bill, but that the Governor remains largely opposed to legalization. Governor Carney has previously expressed concerns that cannabis may act as a so-called 'gateway drug' and has said that he doesn't believe that legalizing it is a "good idea."

However, in recent years, the Governor has nonetheless signed various marijuana reform bills into law – including legislation removing criminal penalties for cannabis possession for minors as well as legislation expanding the pool of health care practitioners eligible to provide medical marijuana authorizations.

NORML's Executive Director Erik Altieri said, "We applaud the Delaware legislature for passing this important legislation. The overwhelming majority of Delaware residents support ending their state's failed prohibition on marijuana, and Governor Carney should respect the will of the people."

Laura Sharer, Executive Director of Delaware NORML added: "The collateral consequences of the thousands of cannabis possession offenses that occur every year in Delaware extend far beyond fines. It's time to right these immense wrongs. We can now work to accept cannabis use as an issue of personal choice, not criminal behavior."

Separate legislation (HB 372) that seeks to legalize and regulate the retail sale of marijuana and marijuana products is still pending before lawmakers. Previous attempts to pass legislation to regulate and tax marijuana sales stalled in the Senate, which requires a three-fifths majority vote to approve any measure that establishes new taxes.

Clinical Trial: Topical CBD Ointment Efficacious for Psoriasis

Bangkok, Thailand: The topical application of an ointment containing 2.5 percent CBD improves symptoms of psoriasis, according to the findings of a randomized, placebo-controlled study published in the Journal of the European Academy of Dermatology and Venerology.

A team of investigators affiliated with King Chulalongkorn University Hospital and Thammasat University Hospital in Thailand assessed the twice daily application of either CBD or placebo over a 12-week period in 51 patients with mild plaque-type psoriasis.

Areas treated with CBD showed significant improvements compared to areas treated with the placebo. Researchers did not identify any adverse effects attributable to the use of CBD.

"Our results indicated a trend of favorable response in the treatment with CBD, which has emerged as a therapeutic option for psoriasis," authors concluded. "These outcomes will pave the way for future studies on [the] therapeutic effects of CBD."

Prior studies have previously shown that CBD may reduce certain types of skin inflammation, including erythema, pruritis, and acne.

Full text of the study, "Topical cannabidiol-based treatment for psoriasis: A dual-centered randomized, placebo-controlled study," appears in theJournal of the European Academy of Dermatology and Venerology.

Analysis: Reduced Taxes, Fewer Regulatory Burdens Would Promote Better Growth in California's Licensed Cannabis Market

Los Angeles, CA: Regulatory costs, high taxes, and municipal bans on cannabis retailers have significantly inhibited the growth of the licensed marijuana marketplace in California, according to a report issued by the Reason Foundation.

The analysis estimated that California imposes an effective tax rate of as much as $92 per ounce. This amount is higher than the tax burden imposed on retail cannabis transactions in other states.

The report's author also highlighted that California has a "paucity of legal retailers" as compared to other adult-use states. This is because the majority of localities in California prohibit such establishments. While Colorado has "one legal retailer per 13,838 residents" and "Oregon boasts one retailer per 6,145 residents," California has "one legal retailer per 29,282 residents, indicating a dramatic undersupply of legal retailers in the Golden State."

California NORML Director Dale Gieringer, who authored the report's foreword wrote: "California's legal industry has been hard pressed to compete with untaxed, unregulated providers on the underground market. So dire is the current situation that advocates now fear that the cannabis industry in California faces an 'existential crisis' in the absence of meaningful tax reform."

He concluded, "Substantive tax cuts therefore seem to be a feasible strategy for reducing demand for the illicit market, while still retaining reasonable revenues for the state programs funded in Prop. 64."

Following the report's release, Democratic Gov. Gavin Newsom proposed eliminating the marijuana cultivation tax. Doing so requires support from two-thirds of the state legislature.

Full text of the report, "The Impact of California Cannabis Taxes on Participation Within the Legal Market," is available from the Reason Foundation.

#NORML #News @WeedConnection

WeedConnection @ Twitter @WeedConnection @ Facebook @WeedConnection @ LinkedIn @WeedConnection @ Foursquare @WeedConnection @ Spotify @WeedConnection @ YouTube

#FollowFriday @RussellRope #OG @WeedConnection

Share This
* New Show NQ @TheTrueOGReport *

* READ & Click & READ & Click *

:: Creator @ WC @ RR Productions ::
:: Follow @RussellRope For Updates ::

#OG @RussellRope #Creator @WeedConnection

:: Join The Revolution ::
:: Read & Take Action ::
:: True OG Stories @ RR ::
:: SUPREME #LegalTrillOG ::

----------------------------------

:: Media Marketing Services @ RRP ::

:: Connect | ADVERTISE | Work | Submit ::

:: Subscribe | Follow | Share | Like | Support ::

:: #FreeTheWeed @WeedConnection ::

WeedConnection @ Twitter @WeedConnection @ Facebook @WeedConnection @ LinkedIn @WeedConnection @ Foursquare @WeedConnection @ Spotify @WeedConnection @ YouTube @WeedConnection @ Yelp @WeedConnection @ Google+ @WeedConnection @ instaGram

weedconnection.com

#iNTERNATiONAL #DiRECTORY @WeedConnection

Share This

New directory with maps etc. in development....
LiMiTed oFFeR: dOuBLe DuRAtiON oF NeW LiSTiNGs (wHiLe sTiLL iN DeV mOde)
oR 10% DiScOuNt :: Select You Plan @ [click here]

Ask about our current promotion, which is a free listing with purchase of any other service @WeedConnection. Recently started rebuilding our global database and added a new/temp delivery section to our directory. Send us an email to submit any current information. Click here for listing and advertising information. The directory is a huge project that requires maintenance. We still have big plans for future development and production. Join(t) the team as a regional manager, college intern, street team member, or click here for a list of other open positions. Support, subscribe, follow, share, like, and mention growing cannabis business @WeedConnection


#iNTERNATiONAL #Directory

WeedConnection @ Twitter @WeedConnection @ Facebook @WeedConnection @ LinkedIn @WeedConnection @ Foursquare @WeedConnection @ Spotify @WeedConnection @ YouTube @WeedConnection @ Yelp @WeedConnection @ Google+ @WeedConnection @ instaGram

weedconnection.com

#SocialMedia @WeedConnection

Share This


:: FYi FB/iG Terminated WC Accts Again ::
:: No Just Cause FB iS Run By Sociopaths ::
:: They iNvested iN Criminal Competition ::
:: See Fed RiCO Lawsuit @ SCOTUS @ RR ::
. . . .

:: Join Us For A Hollyweed Sesh ::
:: Subscribe, Follow, Like, Add, Share ::

@WeedCONNECTiON

#SocialMedia @WeedConnection

SOCIAL:
twitter.com/weedconnection
instagram.com/weedconnection
facebook.com/weedconnection
myspace.com/weedconnection420
youtube.com/weedconnection420

BUSINESS:
weedconnection.com
weedconnection.com/advertise

CREATOR:
@RussellRope @ russellrope.com/blog

#Support Your #OG(s)
#LinkUP @WeedConnection

@WeedConnection .com



Email:

#FreeTheOG
#FreeTheWeed
Fund WC++

Read RR True Story
Connect | ADVERTISE | Work | Submit
Subscribe | Follow | Share | Like | Support

WeedConnection @ Twitter @WeedConnection @ Facebook @WeedConnection @ LinkedIn @WeedConnection @ Foursquare @WeedConnection @ Spotify @WeedConnection @ YouTube @WeedConnection @ Yelp @WeedConnection @ Google+ @WeedConnection @ instaGram

weedconnection.com

 

#NORML #News @WeedConnection

Share This

Survey: Super-Majority of Americans Oppose Federal Marijuana Prohibition

Washington, DC: Only two in ten Americans support the federal criminalization of marijuana, according to nationwide polling data compiled by YouGov.com.

Pollsters asked respondents whether cannabis use ought to be either "legalized nationally, left up to the states, or banned nationally."

Forty-five percent of those surveyed said that it should be legalized nationwide. Twenty-one percent of respondents said the decision to legalize cannabis should be left up to each individual state. Only 20 percent of those surveyed said they supported maintaining federal cannabis prohibition.

Democrats were far more likely than Republicans to support a policy of nationwide legalization.

Several pieces of legislation – including the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act and the States Reform Act – are pending in Congress to repeal federal marijuana prohibition, thereby permitting state governments to decide their own cannabis policies free from undue federal interference.

Study: Young Adults' Consumption of Alcohol, Cigarettes, Other Substances Fell Following Marijuana Legalization

Seattle, WA: Retail cannabis sales are associated with decreases in the use of alcohol, cigarettes, and pain medications by young adults, according to data published in the Journal of Adolescent Health.

Researchers with the University of Washington assessed trends in alcohol, nicotine, and non-prescribed pain reliever use among a cohort of over 12,500 young adults (ages 18 to 25) in Washington State following adult-use cannabis legalization.

They reported, "Contrary to concerns about spillover effects, implementation of legalized nonmedical cannabis coincided with decreases in alcohol and cigarette use and pain reliever misuse." Researchers did find that the prevalence of past-month e-cigarette use increased post-legalization.

Authors concluded, "Our findings add to evidence that the legalization of nonmedical cannabis has not led to dramatic increases in the use of alcohol, cigarettes, and nonprescribed opioids. … The findings indicate that the most critical public health concerns surrounding cannabis legalization and the evolution of legalized cannabis markets may be specific to cannabis use and related consequences."

Commenting on the study's findings, NORML's Deputy Director Paul Armentano said: "Real-world data from legalization states disputes longstanding claims that cannabis is some sort of 'gateway' substance. In fact, in many instances, cannabis regulation is associated with the decreased use of other substances, including many prescription medications."

Numerous prior studies, including those conducted by The RAND Corporation and the National Academy of Sciences, have disputed the so-called 'gateway theory' - concluding, "[M]arijuana has no causal influence over hard drug initiation."

According to nationwide polling compiled by YouGov.com, a majority of Americans no longer agree with the notion that "the use of marijuana leads to the use of hard drugs."

Full text of the study, "Trends in alcohol, cigarette, e-cigarette, and nonprescribed pain reliever use among young adults in Washington state after legalization of nonmedical cannabis," appears in the Journal of Adolescent Health.

Delaware: Lawmakers Advance Legislation Eliminating Marijuana Possession Penalties

Dover, DE: Majorities of lawmakers in the House and Senate have approved legislation, House Bill 371, eliminating penalties for the possession of up to one ounce of cannabis by adults.

House members voted 26 to 14 and Senate members voted 13 to 7 to advance the legislation. Virtually all Democrats voted for the measure while the majority of Republicans decided against it.

A spokesperson for Democratic Gov. John Carney said that he will review the bill, but that the Governor remains largely opposed to legalization. Governor Carney has previously expressed concerns that cannabis may act as a so-called 'gateway drug' and has said that he doesn't believe that legalizing it is a "good idea."

However, in recent years, the Governor has nonetheless signed various marijuana reform bills into law – including legislation removing criminal penalties for cannabis possession for minors as well as legislation expanding the pool of health care practitioners eligible to provide medical marijuana authorizations.

NORML's Executive Director Erik Altieri said, "We applaud the Delaware legislature for passing this important legislation. The overwhelming majority of Delaware residents support ending their state's failed prohibition on marijuana, and Governor Carney should respect the will of the people."

Laura Sharer, Executive Director of Delaware NORML added: "The collateral consequences of the thousands of cannabis possession offenses that occur every year in Delaware extend far beyond fines. It's time to right these immense wrongs. We can now work to accept cannabis use as an issue of personal choice, not criminal behavior."

Separate legislation (HB 372) that seeks to legalize and regulate the retail sale of marijuana and marijuana products is still pending before lawmakers. Previous attempts to pass legislation to regulate and tax marijuana sales stalled in the Senate, which requires a three-fifths majority vote to approve any measure that establishes new taxes.

Clinical Trial: Topical CBD Ointment Efficacious for Psoriasis

Bangkok, Thailand: The topical application of an ointment containing 2.5 percent CBD improves symptoms of psoriasis, according to the findings of a randomized, placebo-controlled study published in the Journal of the European Academy of Dermatology and Venerology.

A team of investigators affiliated with King Chulalongkorn University Hospital and Thammasat University Hospital in Thailand assessed the twice daily application of either CBD or placebo over a 12-week period in 51 patients with mild plaque-type psoriasis.

Areas treated with CBD showed significant improvements compared to areas treated with the placebo. Researchers did not identify any adverse effects attributable to the use of CBD.

"Our results indicated a trend of favorable response in the treatment with CBD, which has emerged as a therapeutic option for psoriasis," authors concluded. "These outcomes will pave the way for future studies on [the] therapeutic effects of CBD."

Prior studies have previously shown that CBD may reduce certain types of skin inflammation, including erythema, pruritis, and acne.

Full text of the study, "Topical cannabidiol-based treatment for psoriasis: A dual-centered randomized, placebo-controlled study," appears in theJournal of the European Academy of Dermatology and Venerology.

Analysis: Reduced Taxes, Fewer Regulatory Burdens Would Promote Better Growth in California's Licensed Cannabis Market

Los Angeles, CA: Regulatory costs, high taxes, and municipal bans on cannabis retailers have significantly inhibited the growth of the licensed marijuana marketplace in California, according to a report issued by the Reason Foundation.

The analysis estimated that California imposes an effective tax rate of as much as $92 per ounce. This amount is higher than the tax burden imposed on retail cannabis transactions in other states.

The report's author also highlighted that California has a "paucity of legal retailers" as compared to other adult-use states. This is because the majority of localities in California prohibit such establishments. While Colorado has "one legal retailer per 13,838 residents" and "Oregon boasts one retailer per 6,145 residents," California has "one legal retailer per 29,282 residents, indicating a dramatic undersupply of legal retailers in the Golden State."

California NORML Director Dale Gieringer, who authored the report's foreword wrote: "California's legal industry has been hard pressed to compete with untaxed, unregulated providers on the underground market. So dire is the current situation that advocates now fear that the cannabis industry in California faces an 'existential crisis' in the absence of meaningful tax reform."

He concluded, "Substantive tax cuts therefore seem to be a feasible strategy for reducing demand for the illicit market, while still retaining reasonable revenues for the state programs funded in Prop. 64."

Following the report's release, Democratic Gov. Gavin Newsom proposed eliminating the marijuana cultivation tax. Doing so requires support from two-thirds of the state legislature.

Full text of the report, "The Impact of California Cannabis Taxes on Participation Within the Legal Market," is available from the Reason Foundation.

#NORML #News @WeedConnection

WeedConnection @ Twitter @WeedConnection @ Facebook @WeedConnection @ LinkedIn @WeedConnection @ Foursquare @WeedConnection @ Spotify @WeedConnection @ YouTube

#FollowFriday @RussellRope #OG @WeedConnection

Share This
* New Show NQ @TheTrueOGReport *

* READ & Click & READ & Click *

:: Creator @ WC @ RR Productions ::
:: Follow @RussellRope For Updates ::

#OG @RussellRope #Creator @WeedConnection

:: Join The Revolution ::
:: Read & Take Action ::
:: True OG Stories @ RR ::
:: SUPREME #LegalTrillOG ::

----------------------------------

:: Media Marketing Services @ RRP ::

:: Connect | ADVERTISE | Work | Submit ::

:: Subscribe | Follow | Share | Like | Support ::

:: #FreeTheWeed @WeedConnection ::

WeedConnection @ Twitter @WeedConnection @ Facebook @WeedConnection @ LinkedIn @WeedConnection @ Foursquare @WeedConnection @ Spotify @WeedConnection @ YouTube @WeedConnection @ Yelp @WeedConnection @ Google+ @WeedConnection @ instaGram

weedconnection.com

#NORML #News @WeedConnection

Share This

Study: Patients with Insomnia Report Improvements with Medical Cannabis

Ottawa, Canada: Patients with insomnia and other sleep disorders report subjective improvements following the use of cannabis and a significant percentage of them report being able to either reduce or discontinue their use of prescription medications, according to data published in the Canadian Pharmacists Journal.

Canadian investigators assessed the impact of marijuana on sleep disorders in a cohort of 38 patients authorized to access medical cannabis products. Patients were assessed at baseline and then three months after initiating cannabis.

Investigators reported that 71 percent of patients experienced subjective improvement in their sleep. Thirty-nine percent of the study's subjects were able to either "completely discontinue [their use of] insomnia medications or reduce their use from nightly administration to as-needed administration with the use of medical cannabis."

The study's results are consistent with other observational studies, such as those here and here, finding that patients with sleep disorders typically experience improvements in their symptoms from cannabis.

Authors concluded, "[O]ngoing clinical trials of cannabinoids in patients living with insomnia are integral to ensuring evidence-based decisions on the role of cannabinoid therapies in the treatment of sleep disorders."

Full text of the study, "Cannabis use in patients with insomnia and sleep disorders: Retrospective chart review," appears in theCanadian Pharmacists Journal.

Survey: Use of Medical Cannabis Associated with Sustained Improvements in Anxiety, Depression

Calgary, Canada: Patients with symptoms of anxiety and/or depression report sustained improvements following the use of cannabis, according to survey data published in the journal Psychiatry Research.

Canadian investigators surveyed over 7,000 patients authorized to access medical cannabis products. The average age of subjects in the study was 50 years old. All of the study's subjects belonged to a licensed Canadian medical cannabis clinic.

Authors reported "statistically significant improvements" between subjects' baseline and follow up scores on validated measurements of anxiety and depression. Symptom improvements were sustained for at least one year.

"To our knowledge, this study is the largest completed to date examining the impact of medical cannabis use on anxiety and depression outcomes utilizing longitudinal data and validated questionnaires," they concluded. "It provides evidence on the effectiveness of medical cannabis as a treatment for anxiety and depression that otherwise is not currently available, demonstrating that patients who seek treatment with medical cannabis for anxiety and depression can experience clinically significant improvements. This study offers reasonable justification for the completion of large clinical trials to further the understanding of medical cannabis as a treatment for anxiety and depression."

Full text of the study, "Medical cannabis use in Canada and its impact on anxiety and depression: A retrospective study," appears in Psychiatric Research.

Survey: Parkinson's Disease Patients Report Improved Symptoms, Decreased Prescription Drug Use Following Cannabis Initiation

Aurora, CO: Patients with Parkinson's Disease (PD) report improved symptom management and reduced prescription drug use following the use of cannabis, according to survey data published in the journal Movement Disorders Clinical Practice.

A team of investigators with the University of Colorado Anschutz Medical Campus surveyed 1,881 PD patients regarding their use of cannabis products.

Respondents most commonly reported improvements in sleep, pain, anxiety, and agitation following their use of either CBD or whole-plant cannabis products. Those subjects who primarily used high-potency THC products also reported improvements in nausea, appetite, depression and tremor, but were also more likely to report worsening symptoms of bradykinesia (slowness of movement). Consistent with prior studies, many respondents reported either decreasing or discontinuing their use of certain prescription drugs - particularly those prescribed for pain and anxiety.

"These survey results offer a broad overview of real‐world cannabis use patterns and experience among a large group of people living with PD and provide initial results regarding the differential symptomatic effects of higher THC versus higher CBD products," authors concluded. "In summary, people with PD report that cannabis subjectively improves some PD‐related symptoms, with higher THC products conferring more frequent benefits than higher CBD products. ... Next steps should include more rigorous, controlled studies, informed by the results herein, to more objectively study the effects of varying types of cannabis on PD symptoms, as well the impact of the different methods of ingestion and specific doses."

Human trials from Israel and Brazil have documented improvements in PD patients' symptoms and quality of life following their use of either inhaled cannabis or oral CBD extracts.

Full text of the study, "Higher risk, higher reward? Self-reported effects of real-world cannabis use in Parkinson's Disease," appears in Movement Disorders Clinical Practice.

Analysis: 'Hemp Derived Delta-9-THC' Products Seldom Come as Advertised

Tustin, CA: Many commercially available products marketed as 'hemp-derived delta-9-THC' are mislabeled and most are not lab tested for heavy metals or other potential impurities, according to an analysis provided by the consumer research firm CBD Oracle.

Investigators purchased 53 commercially available products and had them independently lab tested.

They reported that nearly two-thirds of the products contained synthetically derived THC, despite many claiming to be 'all natural.' This result is not surprising because hemp typically contains only trace quantities of either delta-9-THC or delta-8-THC. In most cases, unregulated products that are promoted as containing either 'hemp-derived' delta-8-THC or delta-9-THC actually contain THC that has been chemically converted from hemp-derived CBD. Manufacturers engaged in synthesizing THC are not subject to regulatory oversight and often use potentially dangerous household products to facilitate this process.

The study's authors also reported that over half of the products contained THC levels that differed significantly from what was advertised on the product's packaging - a finding that is consistent with other analyses of unregulated, hemp-derived products. Most of the mislabeled products contained far lower percentages of THC than advertised, with some products containing zero percent THC. Authors further noted that most of the products' manufacturers failed to test them for impurities, like pesticides and heavy metals.

In response to the analysis, Erika Stark of the National Hemp Association said: "The FDA needs to create a reasonable framework that accounts for all cannabinoids. New cannabinoids products are going to continue to be developed. ... At this pace, we're all going to die of old age before there's proper regulation in place to address all of these issues."

NORML and other groups have repeatedly urged the US Food and Drug Administration to provide regulatory guidelines overseeing the production, testing, labeling, and marketing of hemp-derived products containing either CBD or THC. Nevertheless, more than three years following the passage of federal legislation legalizing hemp production, the FDA has yet to promulgate rules regulating the marketing and sale of these commercially available products.

Full text of the CBD Oracle report is available online.

#NORML #News @WeedConnection

WeedConnection @ Twitter @WeedConnection @ Facebook @WeedConnection @ LinkedIn @WeedConnection @ Foursquare @WeedConnection @ Spotify @WeedConnection @ YouTube